Gastrointestinal complications in renal transplant recipients

被引:135
作者
Ponticelli, C
Passerini, P
机构
[1] IRCCS, Ist Auxol Italian, Clin Immunol Unit, Milan, Italy
[2] Osped Maggiore, IRCCS, Dept Nephrourol, Milan, Italy
关键词
gastrointestinal complications; immunosuppressive therapy; renal transplantation; renal transplantation complications;
D O I
10.1111/j.1432-2277.2005.00134.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Gastrointestinal complications are frequent in renal transplant recipients and can include oral lesions, esophagitis, peptic ulcer, diarrhea, colon disorders and malignancy. Oral lesions may be caused by drugs such as cyclosporine and sirolimus, by virus or fungal infections. Leukoplakia may develop in patients with Epstein-Barr virus (EBV) infection. The commonest esophageal disorder is represented by fungal esophagitis usually caused by candida. A number of patients may suffer from nausea, vomiting and gastric discomfort. These disorders are more frequent in patients treated with mycophenolate mofetil (MMF). Peptic ulcer is more rare than in the past. Patients with a history of peptic ulcer are particularly prone to this complication. Other gastroduodenal disorders are caused by cytomegalovirus (CMV) and herpes simplex infection. Diarrhea is a frequent disorder which may be caused by pathogen microorganisms or by immunosuppressive agents. The differential diagnosis may be difficult. Colon disorders mainly consist of hemorrhage, usually sustained by CMV infection, or perforation which may be caused by diverticulitis or intestinal ischemia. Colon cancer, anal carcinoma, and EBV-associated lymphoproliferative disorders are particularly frequent in transplant recipients. A particular gastric lymphoma. called mucosa-associated lymphoid tissue (MALT) lymphoma may develop in renal transplant patients. It usually responds to the eradication of Helicobacter pylori.
引用
收藏
页码:643 / 650
页数:8
相关论文
共 67 条
[1]  
Amaro R, 2002, AM J GASTROENTEROL, V97, P2220
[2]   Increased incidence of gastrointestinal surgical complications in renal transplant recipients with polycystic kidney disease [J].
Andreoni, KA ;
Pelletier, RP ;
Elkhammas, EA ;
Davies, EA ;
Bumgardner, GL ;
Henry, ML ;
Ferguson, RM .
TRANSPLANTATION, 1999, 67 (02) :262-266
[3]   Maltoma:: A Helicobacter pylori-associated malignancy in transplant patients -: A report from the Israel Penn International Transplant Tumor Registry with a review of published literature [J].
Aull, MJ ;
Buell, JF ;
Peddi, VR ;
Trofe, J ;
Beebe, TM ;
Hanaway, MJ ;
Roy-Chaudhury, P ;
Alloway, RR ;
First, MR ;
Woodle, ES .
TRANSPLANTATION, 2003, 75 (02) :225-228
[4]   CHRONIC NICOTINE INTAKE CAUSES VASCULAR DYSREGULATION IN THE RAT GASTRIC-MUCOSA [J].
BATTISTEL, M ;
PLEBANI, M ;
DIMARIO, F ;
JOCIC, M ;
LIPPE, IT ;
HOLZER, P .
GUT, 1993, 34 (12) :1688-1692
[5]   Mycophenolate mofetil - Suggested guidelines for use in kidney transplantation [J].
Behrend, M .
BIODRUGS, 2001, 15 (01) :37-53
[6]   GASTROINTESTINAL COMPLICATIONS IN RENAL-TRANSPLANTATION [J].
BENOIT, G ;
MOUKARZEL, M ;
VERDELLI, G ;
HIESSE, C ;
BUFFET, C ;
BENSADOUN, H ;
CHARPENTIER, B ;
JARDIN, A ;
FRIES, D .
TRANSPLANT INTERNATIONAL, 1993, 6 (01) :45-49
[7]   Enteric coating of mycophenolate sodium: A rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate [J].
Bjarnason, I .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) :3238-3240
[8]   Gastrointestinal infections caused by cytomegalovirus [J].
David A. Bobak .
Current Infectious Disease Reports, 2003, 5 (2) :101-107
[9]   Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study [J].
Budde, K ;
Curtis, J ;
Knoll, G ;
Chan, L ;
Neumayer, HH ;
Seifu, Y ;
Hall, M .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) :237-243
[10]   Massive gastrointestinal hemorrhage in a renal transplant recipient due to visceral Kaposi's sarcoma [J].
Calzona, A ;
Naso, P ;
Puliatti, C ;
Veroux, PF ;
Leone, F ;
Russo, A .
ENDOSCOPY, 2002, 34 (02) :179-179